SCHEMBL220528

SCHEMBL220528

CCCCCCCCCC(=O)c1ccc(O)c(C(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KAT8 Q9H7Z6 2/20 0.60
HSD17B3 P37058 7/20 0.59
HTT P42858 2/20 0.51
FFAR1 O14842 1/20 0.50
PLA2G2A P14555 1/20 0.50
PLA2G5 P39877 1/20 0.50
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
KMT2A Q03164 1/20 0.50
ATM Q13315 1/20 0.50
STS P08842 4/20 0.49
PPARA Q07869 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30182775 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL29406518 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL222170 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL10595067 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL29623899 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL31751243 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL10594259 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL1576935 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL82454 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A
SCHEMBL9087168 1.00 KAT8 (0.60) KAT8HSD17B3HTTFFAR1PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 513 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144729-A1 A CLEANSING COMPOSITION L'OREAL (FR) 2026-05-28 US claimed
EP-3558234-B1 PRESERVING AGENT COMPRISING 4-(3-ETHOXY-4-HYDROXYPHENYL)-2-BUTANONE, AND USE THEREOF IN COSMETIC COMPOSITIONS OREAL (FR) 2025-12-17 EP claimed
US-20250367087-A1 COMPOSITION FOR CLEANSING THE HAIR L'OREAL (FR) 2025-12-04 US claimed
EP-4611719-A1 A CLEANSING COMPOSITION L'OREAL (FR) 2025-09-10 EP claimed
EP-4608352-A1 AQUEOUS MAKE-UP-REMOVING COMPOSITION HAVING A MILD PEELING EFFECT L'OREAL (FR) 2025-09-03 EP claimed
US-20250221902-A1 COMPOSITION FOR CLEANSING THE HAIR L'OREAL (FR) 2025-07-10 US claimed
CN-120076784-A Cleaning composition 莱雅公司 2025-05-30 CN claimed
CN-120035430-A Composition for conditioning hair 莱雅公司 2025-05-23 CN claimed
EP-4554550-A1 COMPOSITION FOR CLEANSING THE HAIR L'OREAL (FR) 2025-05-21 EP claimed
EP-4531802-A1 COMPOSITION FOR CLEANSING THE HAIR L'OREAL (FR) 2025-04-09 EP claimed
EP-0997140-B1 Skin and/or hair whitening composition OREAL (FR) 2001-04-11 EP claimed
EP-0875495-B1 New derivatives of salicylic acid and their use in cosmetic and/or dermatological compositions OREAL (FR) 2000-06-21 EP claimed
US-5997885-A Cosmetic and/or dermatological composition containing thermal spring water or mineral water and an active agent, in order to combat acne or aging L'OREAL (FR) 1999-12-07 US claimed
US-5690946-A REDUCING IRRITATION L'OREAL (FR) 1997-11-25 US claimed
EP-0765658-B1 Use of salicylic acid derivatives for the treatment of striae OREAL (FR) 1997-11-19 EP claimed
EP-0747043-B1 Use of salicylic acid derivatives for skin whitening OREAL (FR) 1997-04-09 EP claimed
EP-0699432-B1 Cosmetic and/or dermatologic composition containing thermal or mineral water and an active agent against acne or ageing OREAL (FR) 1997-01-15 EP claimed
US-5262407-A Antiaging compounds, decoloring and softeners L'OREAL (FR) 1993-11-16 US claimed
EP-0378936-B1 USE OF SALICYLIC-ACID DERIVATIVES IN THE TREATMENT OF AGING OF THE SKIN L'OREAL (FR) 1993-07-14 EP claimed
EP-0336812-B1 ASSOCIATION OF PYRIMIDINE DERIVATIVES AND UREA AND/OR ALLANTOIN DERIVATIVES TO INDUCE AND STIMULATE HAIR GROWTH AND TO REDUCE HAIR LOSS L'OREAL (FR) 1992-08-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250367087-A1 COMPOSITION FOR CLEANSING THE HAIR HSD3B1, CYP27B1, HSD17B7 KAT8 2933/4885HSD17B3 8/4885HTT 378/4885
US-20250221902-A1 COMPOSITION FOR CLEANSING THE HAIR PARG, CUTA, DEGS1 KAT8 1535/4885HSD17B3 59/4885HTT 162/4885
US-20260144729-A1 A CLEANSING COMPOSITION SMURF1, CUTA, S100B KAT8 1409/4885HSD17B3 167/4885HTT 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.